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Biomedical research is increasingly a data-driven science. New technologies support the generation of genome-scale data sets of
sequences, sequence variants, transcripts, and proteins; genetic elements underpinning understanding of biomedicine and disease. Infor-
mation systems designed to manage these data, and the functional insights (biological knowledge) that come from the analysis of these
data, are critical to mining large, heterogeneous data sets for new biologically relevant patterns, to generating hypotheses for experimen-
tal validation, and ultimately, to building models of how biological systems work. Bio-ontologies have an essential role in supporting two
key approaches to eﬀective interpretation of genome-scale data sets: data integration and comparative genomics. To date, bio-ontologies
such as the Gene Ontology have been used primarily in community genome databases as structured controlled terminologies and as data
aggregators. In this paper we use the Gene Ontology (GO) and the Mouse Genome Informatics (MGI) database as use cases to illustrate
the impact of bio-ontologies on data integration and for comparative genomics. Despite the profound impact ontologies are having on
the digital categorization of biological knowledge, new biomedical research and the expanding and changing nature of biological infor-
mation have limited the development of bio-ontologies to support dynamic reasoning for knowledge discovery.
 2006 Elsevier Inc. All rights reserved.
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The era of genome analysis was launched with such
landmark publications as the ﬁrst large-scale survey of
transcriptional activity in the human genome using
expressed sequence tags (ESTs) [1] and the ﬁrst complete
genome of a cellular organism [2]. In relatively quick suc-
cession, the complete genome sequences of several major
biomedical model organisms were published including
yeast (Saccharomyces cerevisiae) [3], nematode (Caenorhab-
ditis elegans) [4], fruit ﬂy (Drosophila melanogaster) [5], and
the laboratory mouse (Mus musculus) [6]. With the avail-
ability of the genome sequences of these model systems
and genome sequence of the human [7,8], biomedical
researchers were able to compare and contrast catalogs of
genome features. The explosion of sequence-based compar-
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minate aspects of human biology and disease [9].
In addition to the analysis of genome features, new tech-
nologies, such as microarrays and massively parallel signa-
ture sequencing, allow researchers to investigate global
transcriptional activity in diﬀerent cell and tissue types
[10,11]. Technologies that permit comprehensive surveys
of the protein content of cells and tissues are rapidly emerg-
ing and will undoubtedly reveal much about the nature of
the proteome and the relationship of the genome, tran-
scriptome, and proteome to one another [12,13].
The challenge of assembling and maintaining a compre-
hensive catalog of an organism’s genome features is
matched by the challenge of managing the range of attri-
bute information associated with these features. Our
knowledge about each genome or cellular component is
both complex and incomplete. Tens of thousands of scien-
tiﬁc papers are published each year that correct old infor-
mation and add new details about millions of distinct
biological entities. One of the major challenges faced by
1 Similar model organism genome databases are maintained for yeast
(http://www.yeastgenome.org/), Drosophila (http://ﬂybase.bio.indiana.
edu/), C. elegans (http://www.wormbase.org/), zebra ﬁsh (http://zﬁn.
org/), and rat (http://rgd.mcw.edu/) among others.
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lyze, and visualize heterogeneous data in ways that lead
to novel insights into biological processes or that lead to
the formulation of a hypothesis that can be tested experi-
mentally. Beyond the annotation of each individual gene,
transcript, and protein in an organism’s genome, is the
much larger challenge of detecting and representing the
networks and interactions of these parts in cells and mul-
ti-cellular complexes. Eventually, the characterization of
these networks will allow biomedical researchers to directly
connect gene function to organismal phenotype.
Coincident with the emergence of genome-scale data
generation technologies has been the development of ontol-
ogies that are speciﬁc for biomedical research domains.
Ontology-based knowledge representations have been and
are being developed in many domains to facilitate informa-
tion extraction and retrieval and to support data interoper-
ability in biology [14,15]. More than dictionaries or
thesauri, bio-ontologies formally represent relationships
between deﬁned biological terms such that the terminolo-
gies can be used both by humans and by computers to
exchange and explore information.
Data integration and comparative genomics are two
common approaches to interpreting genomic data. In this
paper, we explore the impact of bio-ontologies for both
data integration and comparative genomics. Our viewpoint
is a decidedly practical one. The issues we address are not
about the challenges of ontology development per se; rath-
er we focus on how a speciﬁc ontology development eﬀort,
the Gene Ontology, is being used to facilitate data integra-
tion in the organism-speciﬁc Mouse Genome Informatics
(MGI) database and, in the context of information sys-
tems, how it is designed to facilitate sharing biological
knowledge across organisms. We begin by brieﬂy describ-
ing the Gene Ontology (GO) project. We then describe
the Mouse Genome Informatics (MGI) resource and the
role that GO plays in providing semantic consistency to
functional annotations for mouse genes. Finally, we discuss
some of the challenges before us as we move beyond
descriptive models of biological systems to predictive
models.
2. The Gene Ontology: representative Bio-Ontology
The Gene Ontology (GO) project was founded to
advance the development and utilization of bio-ontologies
and semantic standards for molecular biology [16]. The GO
Consortium, the coordinating group for this project, is
developing structured controlled terminologies of terms
for the biological domains of molecular function, biologi-
cal process, and cellular location of gene products. The
GO Consortium members develop the structured set of
terms, deﬁne the relationships and paths between terms,
and then annotate genes and gene products using the terms.
The ontologies and annotations are provided publicly as
part of the GO database resource [http://www.geneontolo-
gy.org/]. Gene Ontology is a work in progress and incorpo-rates community input to help prioritize needed changes
and improvements. Workshops that include domain and
ontology development experts are held on a regular basis
to continue with expansion and improvement of the
resource.
The GO Consortium includes the major model organism
database groups (mouse, ﬂy, yeast, Arabidopsis, worm,
nematode, and rat) and a major sequence database
resource (UniProt). In addition, many other genome anno-
tation groups and bioinformatics centers participate both
in the development of the ontologies and the use of the
GO annotation process for functional annotation systems.
The GO web site provides access to the ontologies, annota-
tions, documentation, bibliography, and tools to support
data analysis using the power of ontological information
structures.
GO has become a community standard for genome
annotations and, together with other ontologies for biology
such as anatomies [17,18] and cell types [19] provides
semantic and ontological representations for biology.
These resources are now essential for the information man-
agement of genetics and genomics data relevant to biomed-
icine. The Open Biological Ontologies resource (http://
obo.sourceforge.net/) provides a repository of community
bio-ontologies.
3. The Mouse Genome Informatics database: representative
database
Mouse Genome Informatics (MGI; http://www.
informatics.jax.org/) is the recognized community database
for the laboratory mouse [20].1 MGI integrates genetic and
genomic data for the mouse in order to fulﬁll its mission as
an informatics resource that facilitates the use of the mouse
as a model system for understanding human biology and
disease processes. MGI provides extensive information
about mouse genes, sequences, alleles, mutant phenotypes,
strain polymorphisms, gene and protein function, develop-
mental gene expression patterns, and curated mammalian
homology data. MGI is also a platform for computational
assessment of integrated biological data with the goal of
identifying candidate genes associated with complex
phenotypes.
Data integration is a primary focus of MGI [21]. Data
integration means identifying disparate data that describe
the same biological entity (e.g., gene, transcript, protein,
etc.). Data integration is critical to knowledge discovery
because it allows diﬀerent information about the same entity
to be related in new ways [22]. Many hurdles to achieving
data integration exist. For example, the same gene can be
referred to by multiple diﬀerent names in the literature. Or,
the same name can be applied to more than one gene. Diﬀer-
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sources. Sequence data obtained from a variety of resources
may include overlapping sequence sets identiﬁed by diﬀerent
primary identiﬁers. In addition to data integration challeng-
es, MGI must deal with incomplete data and inconsistent
data and conﬂicts in data that appear over time.
Key strategies employed by the MGI staﬀ for data inte-
gration include use of unique, permanent accessioned iden-
tiﬁers for major biological entities to preserve cross-
reference integrity and the use of controlled terminologies
and ontologies for functional annotations to achieve
semantic normalization both with mouse-speciﬁc data as
well as across multiple model organism databases. These
integration processes enable comprehensive and accurate
recall of diverse kinds of data. The combination of refer-
ence integrity and semantic normalization enable complex
queries that facilitate knowledge discovery.
4. GO at MGI
The incorporation of the Gene Ontology within MGI
provides semantic integration and access to heterogeneousFig. 1. GO annotations for the Hexa gene in MGI. The molecular function
references and several diﬀerent lines of evidence. The reference numbers are M
provide a subset of the GO annotation record [not included on the web page
example. The columns represented are (A) GO domain—here ‘Molecular Fun
Evidence Code—here ‘IGI’’ for ‘Inferred from Genetic Interaction.’ This provid
method used to provide the data for this annotation; (D) Inferred From—here ‘
interacted in the experiment reported by this annotation. (E) Ref(s)—here ‘J
experiment that informs this annotation row. The MGI journal records link to
gene as well as links to supporting evidence and citations.data sets assembled from data loads and the biomedical lit-
erature. In this context, the ontologies are used as con-
trolled terminologies for the assignment of consistent
functional annotations. The assignment of appropriate
GO terms to genes in MGI enables researchers to retrieve
from the database all genes that are associated with a spe-
ciﬁc biological process, molecular function or cellular
location.
An example of how the Gene Ontology is used to facil-
itate data integration is illustrated by the functional anno-
tation of the mouse hexosaminidase A gene (Hexa,
MGI:96073) in MGI. The gene product of the Hexa gene
is involved in hydrolase activity and one of the GO molec-
ular function terms assigned to this gene by MGI curators
is b-N-acetylhexosaminidase activity (GO:0004563)
(Fig. 1). Data from seven publications support this func-
tional annotation for Hexa [23–29]. Although each of these
papers supports the GO term assignment, the nature of the
evidence in each paper diﬀers and there is substantial var-
iation in the words that the authors of these papers use
to describe the function of Hexa. In this case, GO is used
primarily as a controlled terminology to enforce standardsannotation of b-N-acetylhexosaminidase activity is supported by multiple
GI journal numbers and provide a link to PubMed. The rows of this table
are GO term Accession ID, Taxon ID, etc.]. One row is emphasized for
ction’; (B) GO Term—here ‘b-N-acetylhexosaminidase activity’; (C) GO
es a high-level characterization of the type of experimental or computation
MGI:96074’ is the MGI public Accession ID for the gene with which Hexa
:36305’ is the MGI journal identiﬁer number. This is the citation for the
PubMed. The annotation row, then, provides the GO annotation for the
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standards are one of the keys to data integration [21]. In
the Hexa example above, the advantage of the ontological
structure of GO is not readily apparent. It could be argued
that a simple ﬂat list of terms would suﬃce to achieve inte-
gration in this and similar cases. However, the advantage
of the ontological structure of GO becomes evident when
the retrieval of integrated data becomes necessary or desir-
able. For example, a researcher may wish to retrieve all
mouse genes whose products are involved in ‘lipid metabo-
lism.’ If a simple ﬂat list of controlled terminology terms is
used for functional annotation, each term must be explicit-
ly associated with the gene product in order for the Hexa
gene to be returned in response to this query. Because of
the structure of the GO, however, it is possible to traverse
the relationships of the terms in the GO hierarchy to
retrieve all of the genes that are annotated speciﬁcally to
the term, ‘lipid metabolism,’ but also to any of the child
terms, including ‘sequestering of lipid,’ the actual term to
which Hexa is annotated (Fig. 2).
A further use of GO annotation sets is to provide refer-
ence information that can be used for initial functional
annotations. The comprehensive annotation of well-known
genes provides the reference information that can be used
to provide initial functional annotations for relatively
uncharacterized genes via comparative sequence and
domain analysis (Fig. 3). These computational assignments
are identiﬁed by the evidence and citation information pro-
vided in the annotations, and can thus be included or not
as appropriate for the use of the annotation sets. These ini-
tial annotation assignments can be extremely useful for
experimental biologists making crucial decisions as to allo-
cation of research resources for further characterization of
speciﬁc genes. While the use of GO for functional annota-
tions is a powerful tool for data integration of informationFig. 2. A portion of the GO hierarchy showing the position of ‘lipid metabol
mouse genes with 812 annotations assigned to this term or one of its subterms
with nine annotations. One of the genes annotated to ‘sequestering of lipid’ tefrom the biomedical literature, the curation of the literature
also provides a primary mechanism for continually updat-
ing the GO. All bio-ontologies must evolve as biological
knowledge about genes and gene products emerges. The
curation of literature reveals new and changing knowledge
about biological systems and can result in changes to an
ontology. For example, a recent emphasis by the MGI
curation staﬀ to fully annotate genes involved with the bio-
logical process of ‘regulation of blood pressure’ in the
mouse resulted in 43 new terms being added to the GO.
One immediate consequence of the data aggregation
made available through structured controlled terminolo-
gies is the ability to develop statistical measures that eval-
uate the signiﬁcance of experimental data sets relative to
the complete set of information about a given system.
For example, the analysis of data generated by such gen-
ome-scale technologies as gene microarray data illustrates
the interplay between increasingly global experimental par-
adigms and the critical role that biomedical ontologies play
in interpretation of large-scale data sets [11]. In many
microarray experiments, the outcome is a list of tens to
hundreds of genes that are diﬀerentially expressed in two
or more samples under diﬀerent experimental conditions.
While gleaning biological context from a list of genes is a
daunting task, it is made tractable by knowledgebases
and ontologies. Indeed, a number of software applications
have emerged in recent years that leverage the availability
of Gene Ontology annotations to help researchers identify
biological themes in their gene lists [30].
GO is not the only bio-ontology or structured controlled
terminology included in the MGI resource. The Mouse
Anatomy [18] and the Mammalian Phenotype Ontology
[31] are also used for gene and gene product annotation
by MGI curators. These, along with multiple sets of con-
trolled terminologies, including most prominently the oﬃ-ism’ in the Biological Process ontology. Note that there are, in MGI, 444
. At the level of the ‘sequestering of lipid’ term, there are only eight genes
rm is Hexa.
Fig. 3. The use of structured controlled terminologies enables robust data aggregation and recovery of information. As illustrated here, reviewed
computational analysis (RCA) and inferred from electronic annotation (IEA) assignments of GO terms provide initial annotations for 12 relatively
uncharacterized RIKEN gene models to ‘lipid metabolism’ and its subterms. These annotations provide experimental biologists with initial assessments of
gene characteristics and help in the design of future experiments.
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vide the semantic structure to support the data integration
and retrieval needs of a major bioinformatics resource.
5. Ontologies and comparative genomics
Organism-centric databases such as MGI will continue
to play an important role in biomedical research. Recently,
the availability of sequenced genomes has driven the use of
sequence-based comparative methods. These approaches
have provided tremendous insights into genome organiza-
tion and have revealed novel biological features such as
conserved non-coding regions that are often completely
conserved at the nucleotide level from human to puﬀerﬁsh
[32].
Comparative biology also includes comparing and con-
trasting biological knowledge about the functions and roles
that genes and gene products play in diﬀerent organisms.
GO has provided a common language for describing uni-
versal biological processes which, in turn, has facilitated
both in-depth understanding of biology within a single
organism and for comparing biological processes across
multiple organisms. Consistent use of biological terms
across diﬀerent organisms means that researchers can
retrieve data for a single organism or for multiple organ-
isms accurately and consistently. Being able to compare
data across species makes it possible to use and play to
the strengths of all the diﬀerent model organisms to study
the function of genes. For example, GO annotations for
many genomes are integrated in the GO database
[www.godatabase.org]. Searching the GO database for
annotations to the term ‘sequestering of lipid,’ the term dis-
cussed earlier in this paper, returns 35 gene products from
six organisms [budding yeast, ﬁssion yeast, weed, ﬂy, rat,and mouse] that have been annotated to this term or one
of its subterms. This set of annotations is independent of
the evolutionary relationships between the gene products
(although they might actually be homologs), reﬂecting,
rather, the shared biology. Thus, we can use the combined
expertise in biological annotations for diverse genomes to
provide a robust set of gene products that share a deﬁned
aspect of their biology as another measure of comparative
biology.
6. Biological knowledge in computable form
The examples of data integration and recovery as repre-
sented by the MGI and GO systems demonstrate both the
promise and challenge of data representations. On the one
hand, the use of ontologies and the careful mapping of data
across experimental systems provide a comprehensivemech-
anism to recover robust sets of relevant data in response to
complex queries. On the other hand, these representations
lack the precision in representing the full context surround-
ing knowledge that is described in a typical journal article
comprised of unstructured text, tables, and ﬁgures. To fully
represent the complexities of information presented in a bio-
medical study require a granularity of data representation
for heterogeneous data that is diﬃcult to acquire in comput-
able form. For example, the presentation of phenotype data
from a study of a targeted mutation of a single gene in the
laboratory mouse requires the complete and controlled
description of the genetic construct used, the genotypes of
the mice studied, the details of the experimental assays, the
explanation of the phenotypic results, and the narrative of
the context for the study in relationship to current knowl-
edge. Indeed, changing any one of these contexts can change
the outcome of an experiment and complicate the represen-
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accounts of the experiment as reported in the literature also
include the perspective of the study in relation to humanbiol-
ogy and diseases, often the genesis of the investigation in the
ﬁrst place. Evidence ontologies under development are a crit-
ical next step in the maturation of the bio-ontology ﬁeld.
There are active communities devoted to the representation
of experimental information for microarray [33], toxicoge-
nomic [34], and other experimental data, and more eﬀorts
are under discussion.
The current challenge for data management is to facili-
tate the intersection of the expressiveness of the biomedical
literature with the data retrieval and correlation capabili-
ties of the structure information tracked with ontologies
and stored in databases. The biomedical literature brings
the expertise and experimental results of scientists into
the context of the current knowledge. In the age of geno-
mic-sized data sets, the biomedical literature is increasingly
archaic as a form of transmission of scientiﬁc knowledge
for computers, yet the written word is essential for humans.
Can we improve the computability over biomedical infor-
mation by using bioinformatics tools at the level of bio-
medical publications? Much work in this area has been
undertaken by the natural language processing (NLP) com-
munity with critical assessments undertaken to evaluation
information retrieval using GO annotations [35,36], but
the core indexing of the literature to controlled terminolo-
gies is still primarily undertaken by curators at bioinfor-
matics resources such as the NLM Mesh indexers [37].
Ultimately, the integration of structured terminologies
and bio-ontologies into the scientiﬁc reports as part of
the publication process may provide the means to capture
both the human readable and the computationally tracta-
ble forms of semantic understanding.
7. The role and future of biomedical ontologies
Biomedical ontologies provide the semantic structure
that supports integration and comparison of large, com-
plex data sets in biology. To date, the practical focus for
ontology development and application has been on the
capture of domain knowledge such as function and loca-
tion. Ontologies support uniform data encoding thus
providing semantic integration of information derived
from multiple resources such as free-text publications or
functional annotations of sequences from multiple provid-
ers. Such semantic integration facilitates the exchange and
integration of data between resources and is essential for
future development of semantic web services. Attention
to standards of ontology development [38] ensure these
domain-speciﬁc ontologies are useful as terminologies for
annotation systems and that they can be used in formal
ontological representations in biomedicine as these
resources develop. Bio-ontologies are having a signiﬁcant
impact on data integration, access, and analysis through
their use in capturing and structuring biological data. As
the genomic and biomedical informatics systems coalesce,the bio-ontologies will be of critical importance to the suc-
cess of the data integration and retrieval.
Ultimately, the construction and use of bio-ontologies
as formal, logical systems will enable computational rea-
soning over complex semantic systems. The extension of
bio-ontologies to model or represent biological systems fac-
es formidable challenges, including the representation of
environment, scale, and temporal–spatial context (i.e.,
complexity), as well as the incompleteness and ever chang-
ing nature of biological knowledge. The rapid advances in
development of biomedical ontologies brings both encour-
agements and challenges to our eﬀorts to integrate and
access data for knowledge discovery.
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